New studies link diabetes drug Ozempic to increased risk of NAION, a rare eye condition causing vision loss. Danish Medicines Agency calls for European review.
Novo Nordisk’s Ozempic Under Scrutiny For Potential Increased Risk Of Rare-Eye Disease
Where Today's News Shapes Tomorrow
